Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05709314
PHASE2

A Study of AMDX-2011P in Participants With CAA

Sponsor: Amydis Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with cerebral amyloid angiopathy (CAA).

Official title: A Phase 2, Open-Label Study of AMDX-2011P as a Retinal Tracer in Participants With Cerebral Amyloid Angiopathy (CAA)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2024-07-09

Completion Date

2026-12

Last Updated

2026-02-13

Healthy Volunteers

No

Interventions

DRUG

AMDX-2011P

AMDX-2011P single bolus injection intravenous for diagnostic review

Locations (1)

Associated Retina Consultants

Phoenix, Arizona, United States